Author

Jean-Francois Dufour

May 6, 2023
The Current and Future Burden of Hepatitis B in Switzerland: A Modelling Study
Summary Chronic hepatitis B infection (defined as sustained detection of hepatitis B virus [HBV] surface antigen [HBsAg] protein in serum) is a leading cause of cirrhosis, hepatocellular carcinoma and liver-related deaths. A situation analysis carried out by the Swiss Federal Office of Public Health estimated the HBsAg prevalence in Switzerland to be 0.53% (95% CI: […]

Read More
August 12, 2022
Modelling the Microelimination of Chronic Hepatitis C in the Canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy Goals Despite the Impact of the COVID 19 Pandemic
Summary Since 2014, the Swiss Hepatitis Strategy (SHS) has targeted the elimination of Hepatitis C Virus (HCV) in Switzerland. The epidemiology of HCV is diverse across Swiss cantons, therefore cantonal-level screening and treatment strategies should be developed. This study aimed to identify scenarios to achieve HCV elimination in the canton of Bern by 2030. A […]

Read More